NovImmune
Series BNovImmune raised €36M in a Series B round in Jun 2006. The company is based in Plan-les-Ouates, Switzerland. Investors in the round: Aravis Ventures, LODH Immunology Fund, Novartis Venture Fund and 1 other. Data as of 4 Nov 2026.
Amount raised
€36M
€35,747,591
Native amount
46,000,000 USD
Stage
Series B
series b
Investors
4
Provenance & confidence
UnverifiedAmount
46,000,000 USD
ECB-at-date → €36M · rate 1.2868 on 2006-05-31
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Jun 2006
Round type
series b
Amount (EUR)
€36M